## **Core Concept**
Mesna (sodium 2-mercaptoethane sulfonate) is a protective agent used to prevent hemorrhagic cystitis, a common side effect of certain chemotherapeutic agents. It works by binding to and neutralizing toxic metabolites in the urinary tract.

## **Why the Correct Answer is Right**
Mesna is specifically used to prevent hemorrhagic cystitis caused by ifosfamide and cyclophosphamide, which are alkylating agents used in chemotherapy. These drugs can cause damage to the bladder mucosa through their toxic metabolite acrolein. Mesna binds to acrolein in the urine, forming a non-toxic compound that can be excreted without causing bladder damage. This protective effect makes mesna a crucial adjunct in the management of patients receiving these chemotherapeutic agents.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide any information to evaluate.
- **Option B:** This option is also blank and cannot be assessed.
- **Option C:** Similarly, this option is blank and lacks the necessary details for evaluation.
- **Option D:** This option is blank as well and does not offer any relevant information.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that mesna is specifically used to prevent ifosfamide and cyclophosphamide-induced hemorrhagic cystitis. It does not prevent other side effects of these drugs, such as myelosuppression or alopecia. Mesna is usually administered intravenously along with ifosfamide or cyclophosphamide and sometimes given orally as well for extended protection.

## **Correct Answer:** C. Ifosfamide induced hemorrhagic cystitis.